FDA Panel Nixes OTC Singulair

May 2, 2014 10:11 PM

14 0

FDA Panel Nixes OTC Singulair

Montelukast (Singulair) should not be allowed over-the-counter use for hay fever and other upper respiratory allergy symptoms, an FDA advisory panel recommended Friday.

The advisors voted 11-to-4 against a risk-benefit ratio supportive of OTC use to treat nasal congestion, runny nose, itchy, watery eyes, sneezing, and itching of the nose in adults.

Read more

To category page

Loading...